Clinical Trials Directory

Trials / Completed

CompletedNCT02378324

Effect of Fee on Attendance in Cervical Cancer Screening

Effect of Fee on Attendance in Cervical Cancer Screening-results From ScreenFee a Swedish Population Based Randomised Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,124 (actual)
Sponsor
Göteborg University · Academic / Other
Sex
Female
Age
23 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Several reasons can explain non-attendance in cervical cancer screening. In low resource settings the attendance is even lower. The effect of fee as contributing reason of non attendance has not been studied before why the investigators decided to study this in a low resource setting as a randomised trial.

Detailed description

Non-attendance in the cervical cancer screening programme is the most important factors why Swedish women contract the disease. Low attendance rate is observed in districts with low socioeconomic resources. Several reasons can explain this, including the existence of a fee. A low attendance rate in low resource districts is also noticed in Gothenburg, Sweden. After multiple interventions the coverage has slightly increased. None of the interventions included the aspect of the fee. The investigators decided to study the effect of fee abolishment in a randomized control trial emanating from the regular cervical cancer-screening program. Method: Randomized Control Trial (RCT). Women in low resource areas of Gothenburg, due for screening, January-July 2013, were randomised to receive an offer of a free test or receiving the regular invitation stating the regular fee of 100 Swedish kronor (SEK) (≈11 €). Power calculation has shown 80 % power to detect an increase in participation of 20% at 1972 participants.

Conditions

Interventions

TypeNameDescription
OTHERScreening without feeAll women in three districts in Gothenburg, Sweden, that were eligible for invitation in the regular screening program were individually randomized by computer program in two parallel arms 1:1.

Timeline

Start date
2013-01-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2015-03-04
Last updated
2015-03-04

Source: ClinicalTrials.gov record NCT02378324. Inclusion in this directory is not an endorsement.